Sign inJoin waitlistJoin the waitlist

Vibha Singhal

Fit Clinic Medical Director, Pediatrics Endocrinology · UCLA David Geffen School of Medicine/UCLA Medical Center

Credentials: · · · · · · · ·

History

Pediatrics Endocrinology · UCLA David Geffen School of Medicine/UCLA Medical Center
Present
Pediatric Obesity · UCLA David Geffen School of Medicine/UCLA Medical Center
Present
UCLA David Geffen School of Medicine/UCLA Medical Center
Present

Pediatric Endocrinology
Massachusetts General Hospital
2012–2015
Pediatrics
Mayo Clinic College of Medicine and Science
2005–2008
Harvard School of Public Health
ALL INDIA INST OF MED SCI, ANSARI NAGAR, NEW DELHI, DELHI
2000–2004
All India Institute of Medical Sciences
2002–2003

Research

Clinical review: treatment of pediatric obesity: a systematic review and meta-analysis of randomized trials
Systematic review or meta-analysis · The Journal of Clinical Endocrinology & Metabolism · 2008 · 265 citations
Clinical review: behavioral interventions to prevent childhood obesity: a systematic review and metaanalyses of randomized trials
Systematic review or meta-analysis · The Journal of Clinical Endocrinology & Metabolism · 2008 · 262 citations
Irisin levels are lower in young amenorrheic athletes compared with eumenorrheic athletes and non-athletes and are associated with bone density and strength estimates
PLoS ONE · 2014 · First of 11 authors · 85 citations

Madhusmita Misra
59 papers · 8 as a fellow
Miriam Bredella
39 papers
Fatima Stanford
16 papers
AK
Anne Klibanski
14 papers
KA
Kate Ackerman
13 papers
AB
Amita Bose
12 papers
Karen Miller
12 papers
Brian Carmine
8 papers
IB
Imen Becetti
8 papers · 7 as a fellow
MH
Melanie Haines
8 papers · 2 as a fellow
Deborah Mitchell
7 papers
Elizabeth Lawson
7 papers

Grants

Determinants of Beta Cell Function Following Sleeve Gastrectomy in Adolescents
National Institute of Diabetes and Digestive and Kidney Diseases · K23
Contact PI · $1.1M · Massachusetts General Hospital
2016–2022

Clinical trials

BrainWeighve App Feasibility Study
Principal investigator · Recruiting
University of California, Los Angeles
2023–2027
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
Site PI · Not yet recruiting · Phase 3
Eli Lilly and Company
2026–2032
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2027
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2024–2027